Placeholder Banner

BIO letter to FDA on Labeling for Biosimilar and Interchangeable Biosimilar Products

November 17, 2023

BIO submits specific comments and recommended edits on the draft guidance 2016-D-0643

Download Full Comments Below
Labeling for Biosimilar and Interchangeable Biosimilar Products
Discover More
BIO provided general comments and recommended edits Re: FDA-2023-D-3031
BIO joins 30 other national trade associations in speaking out against unprecedented and burdensome FTC-DOJ regulation of mergers
BIO submits comments in response to the agency’s request for information (FDA-2023-N-3742)